Stem Cells Market And Applications. 2009-2015 - upgrade from electronic to corporate license

This product page is for an upgrade from an electronic license copy to a corporate license. This product can not be purchased as an individual item. The original report will have to be purchased before. Please contact companiesandmarkets.com to discuss the terms before purchasing this product item. If this product is purchased on its own, then this does not entitle you to obtaining the full report.

This item or product page allows customers who have already purchased the "Stem Cells Market And Applications. 2009-2015" report on an electronic license, upgrade to a corporate license and therefore enable the client to distribute the report within their own company and between colleagues working within the same organisation or office.

Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. The major therapeutic use in stem cells market is classified into oncology, cardiology, and bone & cartilage. Among the therapeutic areas, neurology is forecasts to exert highest support to the stem cells market growth with a CAGR of 24.4% during 2010-2015. Hematology and diabetes are expected to lead the stem cell market during 2010-2015.

The stem cell market is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015. The higher growth rate indicates improved industry investments in the Asia-Pacific region in comparison with North America and Europe, going ahead.